These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20663871)

  • 1. Smad7 inhibits transforming growth factor-beta family type i receptors through two distinct modes of interaction.
    Kamiya Y; Miyazono K; Miyazawa K
    J Biol Chem; 2010 Oct; 285(40):30804-13. PubMed ID: 20663871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for inhibitory effects of Smad7 on TGF-β family signaling.
    Murayama K; Kato-Murayama M; Itoh Y; Miyazono K; Miyazawa K; Shirouzu M
    J Struct Biol; 2020 Dec; 212(3):107661. PubMed ID: 33166654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
    Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
    J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibitory effects of Smad6 on bone morphogenetic protein type I receptors.
    Goto K; Kamiya Y; Imamura T; Miyazono K; Miyazawa K
    J Biol Chem; 2007 Jul; 282(28):20603-11. PubMed ID: 17493940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function relationship of inhibitory Smads: Structural flexibility contributes to functional divergence.
    Hariharan R; Pillai MR
    Proteins; 2008 Jun; 71(4):1853-62. PubMed ID: 18175316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crk-associated substrate lymphocyte type regulates transforming growth factor-beta signaling by inhibiting Smad6 and Smad7.
    Inamoto S; Iwata S; Inamoto T; Nomura S; Sasaki T; Urasaki Y; Hosono O; Kawasaki H; Tanaka H; Dang NH; Morimoto C
    Oncogene; 2007 Feb; 26(6):893-904. PubMed ID: 16909115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles for the MH2 domain of Smad7 in the specific inhibition of transforming growth factor-beta superfamily signaling.
    Mochizuki T; Miyazaki H; Hara T; Furuya T; Imamura T; Watabe T; Miyazono K
    J Biol Chem; 2004 Jul; 279(30):31568-74. PubMed ID: 15148321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation.
    Ebisawa T; Fukuchi M; Murakami G; Chiba T; Tanaka K; Imamura T; Miyazono K
    J Biol Chem; 2001 Apr; 276(16):12477-80. PubMed ID: 11278251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratoconus in vitro and the key players of the TGF-β pathway.
    Priyadarsini S; McKay TB; Sarker-Nag A; Karamichos D
    Mol Vis; 2015; 21():577-88. PubMed ID: 26015770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.
    Yan X; Liao H; Cheng M; Shi X; Lin X; Feng XH; Chen YG
    J Biol Chem; 2016 Jan; 291(1):382-92. PubMed ID: 26555259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smad7 inhibits differentiation and mineralization of mouse osteoblastic cells.
    Yano M; Inoue Y; Tobimatsu T; Hendy G; Canaff L; Sugimoto T; Seino S; Kaji H
    Endocr J; 2012; 59(8):653-62. PubMed ID: 22673292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection of Hepatocytes With HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Up-regulating SMAD6 and SMAD7.
    Zhang F; Sodroski C; Cha H; Li Q; Liang TJ
    Gastroenterology; 2017 Jan; 152(1):257-270.e7. PubMed ID: 27693511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
    Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
    EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tollip, an intracellular trafficking protein, is a novel modulator of the transforming growth factor-β signaling pathway.
    Zhu L; Wang L; Luo X; Zhang Y; Ding Q; Jiang X; Wang X; Pan Y; Chen Y
    J Biol Chem; 2012 Nov; 287(47):39653-63. PubMed ID: 23027871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phosphatidylinositol 3-kinase/Akt pathway regulates transforming growth factor-{beta} signaling by destabilizing ski and inducing Smad7.
    Band AM; Björklund M; Laiho M
    J Biol Chem; 2009 Dec; 284(51):35441-9. PubMed ID: 19875456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad7 and Smad6 bind to discrete regions of Pellino-1 via their MH2 domains to mediate TGF-beta1-induced negative regulation of IL-1R/TLR signaling.
    Lee YS; Kim JH; Kim ST; Kwon JY; Hong S; Kim SJ; Park SH
    Biochem Biophys Res Commun; 2010 Mar; 393(4):836-43. PubMed ID: 20171181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
    Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
    Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta signaling is dynamically regulated during the alveolarization of rodent and human lungs.
    Alejandre-Alcázar MA; Michiels-Corsten M; Vicencio AG; Reiss I; Ryu J; de Krijger RR; Haddad GG; Tibboel D; Seeger W; Eickelberg O; Morty RE
    Dev Dyn; 2008 Jan; 237(1):259-69. PubMed ID: 18095342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.